PPAR-γ activation by pioglitazone inhibits microglia-mediated neuroinflammation and alleviates disease in neuromyelitis optica spectrum disorders. [PDF]
Yick LW +6 more
europepmc +1 more source
Statement of Retraction: The role of autophagy-related proteins in the pathogenesis of neuromyelitis optica spectrum disorders. [PDF]
europepmc +1 more source
Atypical Multiple Sclerosis Overlapping Features of Neuromyelitis Optica Spectrum Disorders (NMOSD). [PDF]
Paybast S +3 more
europepmc +1 more source
Emerging Role of Targeted Monoclonal Antibodies in Neuromyelitis Optica Spectrum Disorders. [PDF]
Holian AH, Weinshenker BG.
europepmc +1 more source
The neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with neuromyelitis optica spectrum disorders and multiple sclerosis. [PDF]
Sun Q, Ma X, Zhang L, Tian D.
europepmc +1 more source
Spatiotemporal subtypes of brain and spinal cord atrophy in neuromyelitis optica spectrum disorders and multiple sclerosis. [PDF]
Zhuo Z +18 more
europepmc +1 more source
Predict disabling severe attacks in neuromyelitis optica spectrum disorders: warning symptoms and innovative machine learning models. [PDF]
Zhen W +8 more
europepmc +1 more source
Factors associated with cognitive impairment in patients with neuromyelitis optica spectrum disorders from Mexico. [PDF]
Valdivia-Tangarife ER +11 more
europepmc +1 more source
Cerebellar microstructural and functional connectivity changes in patients with neuromyelitis optica spectrum disorders and their correlation with cognitive function: a female-dominated multimodal MRI study. [PDF]
Zhang Y +7 more
europepmc +1 more source
Neuromyelitis optica spectrum disorders with recurrent syncope due to area postrema syndrome: a case report and literature review. [PDF]
Yin H, Wang Y, Xu Y.
europepmc +1 more source

